ADC Therapeutics SA (ADCT)

NYSE: ADCT · Real-Time Price · USD

4.420

-0.170 (-3.70%)

At close: Oct 10, 2025, 4:00 PM EDT

4.310

-0.110 (-2.49%)

After-hours: Oct 10, 2025, 7:49 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	2015 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	2015 - 2018
Antibody Drug Conjugate Cancer Therapies	70.84M	Log In	Log In	Log In	Log In	Upgrade
Antibody Drug Conjugate Cancer Therapies Growth	1.84%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	2015 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	2015 - 2018
United States	69.28M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	0.32%	Log In	Log In	Log In	Log In	Upgrade
EMEA	1.56M	Log In	Log In	Log In	Log In	Upgrade
EMEA Growth	212.65%	Log In	Log In	Log In	Log In	Upgrade